CardiNor has teamed up with several leading technology partners to secure access to expertise, patient samples and know-how vital for a successful assay development programme. This provides CardiNor with a complete value chain from basic R&D through to production of the final product.
Bioventix is a listed company on LSE. It is a world leading supplier of antibodies to the IVD industry. Its customers include Abbott, Roche, Siemens and bioMerieux. Bioventix has also invested in CardiNor.
Uniogen (former Kaivogen) is a Finnish company specialising in the development and production of ELISA components and finished kits. The company is currently supplying customers in the US and Europe. Uniogen Oy is certified according to the Quality Management System standard ISO 9001:2008 and ISO 13485:2003 by DNV GL.
Mizar Bio (former Axis-Shield lab in Bodø, Norway) is supporting our assay development. The Mizar’s scientists have extensive know-how and a long track record of assay development and technology transfer of several important IVD biomarker assays to proprietary IVD platforms, including PoC instruments.
Akershus University Hospital (AHUS) is home to the research group of professors Torbjørn Omland and Helge Røsjø, who are world leading experts on CVD biomarkers and key scientific advisors to CardiNor. In addition to AHUS, Stavanger University Hospital has supported our clinical trial (SMASH-1), collecting blood samples from patients with ICD implants.